CD4+ TIL to the Rescue of Anti-PD-1 Failure by Targeting MHC-II. Betof Warner A, Luke JJ. Clin Cancer Res 2023;29:3829-3831.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Betof Warner A, Luke JJ. CD4+ TIL to the Rescue of Anti-PD-1 Failure by Targeting MHC-II. Clin Cancer Res 2023;29:3829-3831.
PMID: 37534980